Stride Inc (NY: LRN )
39.52 -0.01 (-0.03%) Official Closing Price Updated: 7:00 PM EDT, Mar 28, 2023 Add to My Watchlist
Headline News about Stride Inc
Where Stride Stands With Analysts
March 10, 2023
Earnings Outlook For K12
January 23, 2023
Stride Company MedCerts Appoints Craig Sprinkle As CEO
November 28, 2022
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 25, 2023
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
Galvanize Appoints Jaime Matyas As CEO
November 21, 2022
Future of School Files Counterclaims Against Stride, Inc. for Breaching Agreement to Donate $2.3 Million
December 09, 2022
Suit alleges Stride reneged on donations despite publicizing support in public filings and ESG reports
Via News Direct
Topics Lawsuit Regulatory Compliance
Exposures Financial Legal Regulatory
A request from a colleague led to today's column. Dividend yield and value investing have been keys to wealth preservation and income accumulation ion the first 11 months of 2011. A quick screen led to...
Stride (NYSE:LRN) has outperformed the market over the past 5 years by 7.83% on an annualized basis producing an average annual return of 16.02%. Currently, Stride has a market capitalization of $1.47...
Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday
October 27, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...
Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session
October 26, 2022
Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following